Canada
· Delayed Price · Currency is CAD Cardiol Therapeutics Statistics
Total Valuation
TSX:CRDL has a market cap or net worth of CAD 123.09 million. The enterprise value is 92.67 million.
| Market Cap | 123.09M |
| Enterprise Value | 92.67M |
Important Dates
The last earnings date was Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:CRDL has 82.61 million shares outstanding. The number of shares has increased by 11.02% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 82.61M |
| Shares Change (YoY) | +11.02% |
| Shares Change (QoQ) | +15.13% |
| Owned by Insiders (%) | 4.70% |
| Owned by Institutions (%) | 9.17% |
| Float | 78.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.98 |
| P/TBV Ratio | 4.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.53 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.69 |
Financial Position
The company has a current ratio of 4.52, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.52 |
| Quick Ratio | 4.41 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -138.47% and return on invested capital (ROIC) is -94.44%.
| Return on Equity (ROE) | -138.47% |
| Return on Assets (ROA) | -73.43% |
| Return on Invested Capital (ROIC) | -94.44% |
| Return on Capital Employed (ROCE) | -162.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.04M |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.92% in the last 52 weeks. The beta is 0.67, so TSX:CRDL's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -37.92% |
| 50-Day Moving Average | 1.53 |
| 200-Day Moving Average | 2.23 |
| Relative Strength Index (RSI) | 53.60 |
| Average Volume (20 Days) | 103,962 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -40.28M |
| Pretax Income | -36.68M |
| Net Income | -36.68M |
| EBITDA | -40.11M |
| EBIT | -40.28M |
| Earnings Per Share (EPS) | -0.51 |
Balance Sheet
The company has 30.58 million in cash and 158,532 in debt, giving a net cash position of 30.42 million or 0.37 per share.
| Cash & Cash Equivalents | 30.58M |
| Total Debt | 158,532 |
| Net Cash | 30.42M |
| Net Cash Per Share | 0.37 |
| Equity (Book Value) | 24.73M |
| Book Value Per Share | 0.30 |
| Working Capital | 24.66M |
Cash Flow
In the last 12 months, operating cash flow was -25.06 million and capital expenditures -21,290, giving a free cash flow of -25.08 million.
| Operating Cash Flow | -25.06M |
| Capital Expenditures | -21,290 |
| Free Cash Flow | -25.08M |
| FCF Per Share | -0.30 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:CRDL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.02% |
| Shareholder Yield | -11.02% |
| Earnings Yield | -29.80% |
| FCF Yield | -20.38% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |